A prospective, randomized controlled, double-blinded study comparing dexmedetomidine and clonidine as an adjuvant to ropivacaine in femoral nerve block for postoperative analgesia in patients undergoing total knee arthroplasty
Suresh, A., Fultambkar, G., Vijayanand, B., Nair, A. (2021). A prospective, randomized controlled, double-blinded study comparing dexmedetomidine and clonidine as an adjuvant to ropivacaine in femoral nerve block for postoperative analgesia in patients undergoing total knee arthroplasty. EKB Journal Management System, 13(1), -. doi: 10.1186/s42077-021-00166-2
Aathira Suresh; Gajanan Fultambkar; B. Vijayanand; Abhijit Nair. "A prospective, randomized controlled, double-blinded study comparing dexmedetomidine and clonidine as an adjuvant to ropivacaine in femoral nerve block for postoperative analgesia in patients undergoing total knee arthroplasty". EKB Journal Management System, 13, 1, 2021, -. doi: 10.1186/s42077-021-00166-2
Suresh, A., Fultambkar, G., Vijayanand, B., Nair, A. (2021). 'A prospective, randomized controlled, double-blinded study comparing dexmedetomidine and clonidine as an adjuvant to ropivacaine in femoral nerve block for postoperative analgesia in patients undergoing total knee arthroplasty', EKB Journal Management System, 13(1), pp. -. doi: 10.1186/s42077-021-00166-2
Suresh, A., Fultambkar, G., Vijayanand, B., Nair, A. A prospective, randomized controlled, double-blinded study comparing dexmedetomidine and clonidine as an adjuvant to ropivacaine in femoral nerve block for postoperative analgesia in patients undergoing total knee arthroplasty. EKB Journal Management System, 2021; 13(1): -. doi: 10.1186/s42077-021-00166-2

A prospective, randomized controlled, double-blinded study comparing dexmedetomidine and clonidine as an adjuvant to ropivacaine in femoral nerve block for postoperative analgesia in patients undergoing total knee arthroplasty

Ain-Shams Journal of Anesthesiology
Volume 13, Issue 1, January 2021  XML PDF (406.53 K)
DOI: 10.1186/s42077-021-00166-2
View on SCiNiTO View on SCiNiTO
Authors
Aathira Suresh; Gajanan Fultambkar; B. Vijayanand; Abhijit Nair email orcid
Abstract
Background
Total knee arthroplasty (TKA) causes significant postoperative pain, imposing a limitation on postoperative mobilization crucial in regaining joint function. Ultrasound (US)-guided femoral nerve block (FNB) in complex knee surgeries is associated with better pain scores and fewer hospital admissions. Alpha-2 (α2) adrenoreceptor agonists have been the recent focus of interest as additives to local anesthetic. We aimed to compare the equivalent dose of dexmedetomidine and clonidine as an adjuvant to ropivacaine in US-guided FNB in TKA. A prospective, randomized, controlled, double-blinded study was conducted involving 80 American Society of Anesthesiologists’ physical status (ASA-PS) I, II, and III patients scheduled to undergo TKA under subarachnoid block. Group 1 ( = 40) patients received 1 μg/kg dexmedetomidine and group 2 ( = 40) patients with 1 μg/kg clonidine as adjuvants added to 20 ml of 0.75% ropivacaine. Duration of postoperative analgesia, pain scores, sedation scores, hemodynamics, rescue analgesia requirement, complications, and patient satisfaction were compared.
Results
The total duration of analgesia in group 1 was better compared to group 2 ( < 0.001).
Conclusion
We conclude that dexmedetomidine added as an adjuvant in FNB increased the duration of analgesia when compared to clonidine with decreased NRS scores, reduced postoperative tramadol requirement, and better sedation and patient satisfaction.
Trial registration
, “Retrospectively registered” on 31 March 2021.
Keywords
total knee arthroplasty; Femoral nerve; nerve block; Regional anesthesia; Dexmedetomidine; Clonidine; Ultrasonography
Statistics
Article View: 10
PDF Download: 10